Cargando…

Variant-dependent oxidative and cytokine responses of human neutrophils to SARS-CoV-2 spike protein and anti-spike IgG1 antibodies

INTRODUCTION: Severe forms of COVID-19, the disease caused by SARS-CoV-2, are characterized by acute respiratory distress syndrome, robust lung inflammation and death in some patients. Strong evidence has been accumulating that polymorphonuclear neutrophilic granulocytes (PMN) play an important role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almeida, Nathalie Bonatti Franco, Fantone, Kayla Marie, Sarr, Demba, Ashtiwi, Nuha Milad, Channell, Sarah, Grenfell, Rafaella Fortini Queiroz, Martins-Filho, Olindo Assis, Rada, Balázs
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613679/ https://www.ncbi.nlm.nih.gov/pubmed/37908356 http://dx.doi.org/10.3389/fimmu.2023.1255003

Ejemplares similares

Dual oxidase 1 is dispensable during Mycobacterium tuberculosis infection in mice
por: Gupta, Tuhina, et al.
Publicado: (2023)

The Hypothiocyanite and Amantadine Combination Treatment Prevents Lethal Influenza A Virus Infection in Mice
por: Ashtiwi, Nuha Milad, et al.
Publicado: (2022)

RGS10 Reduces Lethal Influenza Infection and Associated Lung Inflammation in Mice
por: Almutairi, Faris, et al.
Publicado: (2021)

Coronavirus Disease 2019-Related Alterations of Total and Anti-Spike IgG Glycosylation in Relation to Age and Anti-Spike IgG Titer
por: Schwedler, Christian, et al.
Publicado: (2022)

Neutrophil extracellular traps are present in the airways of ENaC-overexpressing mice with cystic fibrosis-like lung disease
por: Tucker, Samantha L., et al.
Publicado: (2021)

Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers
por: Salvagno, Gian Luca, et al.
Publicado: (2021)

IgG Against Human Betacoronavirus Spike Proteins Correlates With SARS-CoV-2 Anti-Spike IgG Responses and COVID-19 Disease Severity
por: Wang, Jiong, et al.
Publicado: (2022)

Granulocytic Myeloid-Derived Suppressor Cells in Cystic Fibrosis
por: Tucker, Samantha L., et al.
Publicado: (2021)

Anti-SARS-CoV-2 spike IgG antibodies prevalence: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Performance of the Roche/Snibe electrochemiluminescent anti-SARS-COV-2 spike assays compared to the Roche/Abbott IgG nucleocapsid and Abbott IgM spike assays
por: Lau, C.S., et al.
Publicado: (2021)

Sputum from People with Cystic Fibrosis Reduces the Killing of Methicillin-Resistant Staphylococcus aureus by Neutrophils and Diminishes Phagosomal Production of Reactive Oxygen Species
por: Fantone, Kayla M., et al.
Publicado: (2023)

IgG response to spike protein of SARS-CoV-2 in healthy individuals and potential of intravenous IgG as treatment for COVID-19
por: Wang, Gang, et al.
Publicado: (2022)

One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG
por: Capetti, Amedeo F., et al.
Publicado: (2021)

255 A Bacterial Serine Protease Inhibitor, Ecotin Inhibits Neutrophil Elastase in Cystic Fibrosis Airway Samples
por: Fantone, Kayla, et al.
Publicado: (2022)

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
por: Takahashi, Maika, et al.
Publicado: (2022)

Determination of IgG1 and IgG3 SARS-CoV-2 Spike Protein and Nucleocapsid Binding—Who Is Binding Who and Why?
por: Iles, Jason K., et al.
Publicado: (2022)

IgG and IgM antibody formation to spike and nucleocapsid proteins in COVID-19 characterized by multiplex immunoblot assays
por: Shah, Jyotsna, et al.
Publicado: (2021)

Schistosomiasis in Nigeria: Gleaning from the past to improve current efforts towards control
por: Oyeyemi, Oyetunde Timothy, et al.
Publicado: (2020)

Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months
por: Serwanga, Jennifer, et al.
Publicado: (2023)

Rituximab: Humoral immune defect and negative seroconversion IgG-spike 1 test: case report
Publicado: (2022)

Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19
por: Geyer, Chiara E, et al.
Publicado: (2023)

Temporal changes in spike IgG levels after two doses of BNT162b2 vaccine in Japanese healthcare workers: Do spike IgG levels at 3 months predict levels 6 or 8 months after vaccination?
por: Takeuchi, Masaaki, et al.
Publicado: (2022)

Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets
por: Bye, Alexander P., et al.
Publicado: (2021)

IgG Antibodies Develop to Spike but Not to the Nucleocapsid Viral Protein in Many Asymptomatic and Light COVID-19 Cases
por: Tutukina, Maria, et al.
Publicado: (2021)

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes
por: Voss, William N., et al.
Publicado: (2021)

IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection
por: Choudhary, Hari Ram, et al.
Publicado: (2021)

Persistence of Anti-SARS-CoV-2 Spike IgG Antibodies Following COVID-19 Vaccines
por: Alharbi, Naif Khalaf, et al.
Publicado: (2022)

Subclass-switched anti-spike IgG3 oligoclonal cocktails strongly enhance Fc-mediated opsonization
por: Izadi, Arman, et al.
Publicado: (2023)

Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19
por: Smit, Wouter L., et al.
Publicado: (2022)

Case-Control Study of Individuals with Discrepant Nucleocapsid and Spike Protein SARS-CoV-2 IgG Results
por: Wang, Hannah, et al.
Publicado: (2021)

Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction
por: Oshiro, Satoshi, et al.
Publicado: (2021)

Antibodies against spike protein of SARS-CoV-2 variants in bovine whey IgG enriched fraction
por: Oshiro, Satoshi, et al.
Publicado: (2022)

Evaluation of Covid-19 anti-spike IgG antibody five months after the second Covid-19 vaccination
por: Rafie, Reyhaneh Alipoor, et al.
Publicado: (2023)

Susceptibility of influenza viruses to hypothiocyanite and hypoiodite produced by lactoperoxidase in a cell-free system
por: Patel, Urmi, et al.
Publicado: (2018)

Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapy
por: Cosan, Fulya, et al.
Publicado: (2023)

Improvement of POC-CCA Interpretation by Using Lyophilization of Urine from Patients with Schistosoma mansoni Low Worm Burden: Towards an Elimination of Doubts about the Concept of Trace
por: Coelho, Paulo Marcos Zech, et al.
Publicado: (2016)

Development of a high‐sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS‐CoV‐2 spike glycoprotein in serum and saliva
por: Faustini, Sian E., et al.
Publicado: (2021)

Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG
por: Eberhardt, Kirsten Alexandra, et al.
Publicado: (2021)

A Quantitative ELISA Protocol for Detection of Specific Human IgG against the SARS-CoV-2 Spike Protein
por: Vernet, Rémi, et al.
Publicado: (2021)

Quantity of IgG response to SARS-CoV-2 spike glycoprotein predicts pulmonary recovery from COVID-19
por: Nairz, Manfred, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fp6qhj2svnkegkjkv4b5ov092m